A Safety and Tolerability Study of ABT-126 in Elderly

Completed · Phase 1

Conditions studied: Alzheimer's Disease

In brief

The objectives of this study are to assess the safety, tolerability and pharmacokinetics of ABT-126 in elderly subjects.

Key facts

Study ID

NCT00867399

Run by

Abbott

People needed

30

Starts

2009-03-01

Last updated by the study team

2010-11-02

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male or female subjects 65 years or greater.
• Has a MMSE score of 27 or higher.

You may not qualify if…

• History of dementia including by not limited to Alzheimer's disease, Parkinson's disease and mult-infarct dementia.
• History of any significant neurological disease.
• Has an estimated creatinine clearance < 30 mL/min

Where it is running

• Site Reference ID/Investigator# 17283 — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.